I think $100,000,000 is too low. That is equivalent to about $.16 a share. I think this company has much more value than that, easily $.40 as predicted by BioMed Report, but it may take some time.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.